US Point-of-care Diagnostics Market to Reach Revenues of $11 Billion During 2019-2024- Market Research by Arizton

CHICAGO, Feb. 7, 2019 /PRNewswire/ -- Arizton's latest research report states that the US point-of-care diagnostics market is expected to generate revenues of around $11 billion by 2024, growing at a CAGR of more than 7% during 2018-2024.

https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

Key Highlights Offered in the Report:

    --  POC molecular diagnostics will emerge as the next big thing by 2025.
    --  Commercial launch of compact analyzers/instruments will boost the
        moderately growing POC analyzers/instruments segment in the US.
    --  Influx of wearable medical devices, lab-on-a-chip technology, and
        smartphones will create investment opportunities for top vendors.
    --  The introduction of advanced POC analyzers for infectious disease
        testing will transform the US market.
    --  Fecal-occult tests such as Cologuard gains popularity in the US POC
        diagnostics market.
    --  Development of POC analyzers with multiplexing capabilities will offer
        simultaneous on-site measurement of different analytes from a single
        sample.

Key Offerings:

    --  Market Size & Forecast by Revenue | 2018-2024
    --  Market Dynamics - Leading trends, growth drivers, restraints, and
        investment opportunities
    --  Market Segmentation - Detailed analysis of product, technology, usage
        type, and end-users in the US market
    --  Competitive Landscape -Profile leading 3 key vendors, 3 emerging
        companies, and 14 other prominent players

Request your free sample today!https://www.arizton.com/market-reports/us-point-of-care-diagnostics-market#requestsample

US POC Diagnostics Market - Dynamics

The rising application of microfluidic technologies to develop and commercialize advanced clinical diagnostic analyzers will lead to the launch of innovative POC systems in the US market. A few commonly used microfluidics-based analyzers in the market are blood chemistries, nucleic-acid amplification tests, immunoassays, and flow cytometry.

Key drivers and trends fueling the growth of the US market are:

    --  New Product Approvals/Launches
    --  Increasing Number of CLIA Waiver POC Tests
    --  Robust Pipeline and Investigational POC Diagnostic Devices

US POC Diagnostics Market - Segmentation

This market research report includes a detailed segmentation by product, technology, usage type, and end-users.

    --  Blood glucose testing dominated the market share in 2018.
    --  Home care is the fastest growing segment in the market, growing at a
        CAGR of over 7% by 2024.

- Market Segmentation by Product

    --  POC Analyzers
    --  Consumables

- Market Segmentation by Application

    --  Blood Glucose Testing
    --  Cardiovascular and Metabolic Testing
    --  Infectious Disease Testing
    --  Blood Coagulation Testing
    --  Hematology Testing
    --  Cancer Testing
    --  Drugs of Abuse Testing
    --  Pregnancy and Fertility/Ovulation Testing

- Market Segmentation by Usage

    --  Professional POC Diagnostics
    --  At-home POC Diagnostics

- Market Segmentation by End-users

    --  Professional Healthcare Settings
    --  Home Care
    --  Others

Request your free sample today!https://www.arizton.com/market-reports/us-point-of-care-diagnostics-market#requestsample

Major vendors in the US market are:

    --  Abbott
    --  F. Hoffmann-La Roche
    --  Siemens Healthineers

Key companies to watch are:

    --  Danaher
    --  LifeScan
    --  Ascensia Diabetes Care Holdings
    --  Quidel
    --  BD

Other prominent vendors include Abaxis, Acon Laboratories, AgaMatrix, Arbor Vita, bioMérieux, Chembio Diagnostic Systems EKF Diagnostics USA, Exact Sciences, Instrumentation Laboratory, Meridian Bioscience, Sekisui Diagnostics, Sinocare, Sysmex America, Swiss Precision Diagnostics and Trinity Biotech.

Explore our Healthcare vertical to know more about the industry.

Read some of the top selling reports:

    --  Telehealth Market in the US - Industry Outlook and Forecast 2018-2023
    --  Single-use Bioprocessing Market - Global Outlook and Forecast 2019-2024
    --  Drug-Coated Balloons Market - Global Outlook and Forecast 2019-2024
    --  Heart Valve Repair and Replacement Devices Market - Global Outlook and
        Forecast 2018-2023
    --  Companion Animal Diagnostics Market in US - Industry Outlook and
        Forecast 2018-2023
    --  Premature Ejaculation Therapeutics Market - Global Outlook and Forecast
        2019-2024

About Arizton:

Arizton - Advisory and Intelligence is a premium and innovation-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Mail: enquiry@arizton.com
Call:
+1-312-235-2040
+1-302-469-0707

View original content:http://www.prnewswire.com/news-releases/us-point-of-care-diagnostics-market-to-reach-revenues-of-11-billion-during-20192024--market-research-by-arizton-300791549.html

SOURCE Arizton Advisory & Intelligence